Cure My Disease

Don't miss your cure!

 Log in / Sign up

Gentle moves, big heart gains: new study tests baduanjin for heart failure

NCT ID NCT07486791

Symptom relief Sponsor: Xiling Qi Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looks at whether a special sequence of gentle exercises called Baduanjin can improve heart and lung function and quality of life in people who have both acute coronary syndrome and heart failure. About 65 participants will either do these exercises plus standard care or just standard care. Researchers will measure walking distance, heart function, and daily living abilities to see if the exercises help recovery.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 65 people

The number the study aims to enrol. It can still change while the study runs.

Started

Mar 2026

Expected to finish

Jun 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

Up to 85 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Patients meeting the diagnostic criteria for ACS (including unstable angina, non-ST-segment elevation myocardial infarction, and ST-segment elevation myocardial infarction) * Complicated by heart failure during hospitalization * Age ≤ 85 years * Muscle strength ≥ grade 3 * No history of mental illness, conscious and able to cooperate independently with this study * Voluntarily participate in this study and sign the informed consent form Exclusion Criteria: * Patients with persistent heart failure symptoms or NYHA functional class IV despite optimal pharmacological therapy; * Patients with contraindications to cardiac rehabilitation, such as uncontrolled hypertension, uncontrolled arrhythmias, or hemodynamic instability; * Patients with untreated structural heart disease, such as heart failure caused by valvular heart disease or congenital heart disease; * Patients in the acute phase of various diseases, such as severe infection, deep vein thrombosis, or severe hepatic or renal failure; * Patients with disabilities, bone or joint diseases, or neurological disorders that preclude participation in Baduanjin exercises; * Patients with a life expectancy of less than one year; * Patients currently participating in other clinical trials.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Acs (acute coronary syndrome) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

acute chest syndrome acute coronary syndrome heart failure

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Acs (acute coronary syndrome) HF - heart failure

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Second Hospital of Shanxi Medical

    RECRUITING

    Taiyuan, Shanxi, 030001, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.